Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
45,951,901
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
15,201,814
-
Shares change
-
+8,841,461
-
Total reported value, excl. options
-
$24,635,050
-
Value change
-
+$14,327,233
-
Number of buys
-
14
-
Number of sells
-
-8
-
Price
-
$1.62
Significant Holders of Theratechnologies Inc. - Common Shares (THTX) as of Q4 2023
32 filings reported holding THTX - Theratechnologies Inc. - Common Shares as of Q4 2023.
Theratechnologies Inc. - Common Shares (THTX) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15,201,814 shares
of 45,951,901 outstanding shares and own 33% of the company stock.
Largest 10 shareholders include Soleus Capital Management, L.P. (4,801,376 shares), AIGH Capital Management LLC (3,719,302 shares), Nantahala Capital Management, LLC (2,682,228 shares), MORGAN STANLEY (2,259,400 shares), Worth Venture Partners, LLC (906,557 shares), OSAIC HOLDINGS, INC. (128,054 shares), NATIONAL BANK OF CANADA /FI/ (113,378 shares), Cyndeo Wealth Partners, LLC (104,120 shares), STIFEL FINANCIAL CORP (69,058 shares), and Federation des caisses Desjardins du Quebec (54,314 shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.